Ravi Srinivasan Email and Phone Number
Ravi Srinivasan work email
- Valid
- Valid
- Valid
- Valid
- Valid
Ravi Srinivasan personal email
- Valid
Ravi Srinivasan phone numbers
SCOPE►Entrepreneurial biotech executive and technical founder►Track record in leading companies from inception to exit, and developing products from concept through commercialization►Strong technical background as a ScientistRAISING CAPITAL ►Raised over $100MM in funding for companies as a founder and CEO.►Market value of exits >$600MM. CLINICAL TRIALS►Developed products from lab bench through Phase 1, Phase 2 POC and Phase 3 clinical trialsPASSION►Passionate about developing breakthrough first-in-class drug products leveraging novel scientific discoveriesTHERAPEUTIC AREAS ►Oncology, Immunology, Dermatology, Ophthalmology, Obesity, DiabetesEXPERTISE ►C-level senior management and board recruitment►Business plan development, go-to-market strategies►In-licensing►IP portfolio development►Key opinion leader (KOL) recruitment and engagement►Scientific advisory board (SAB) recruitmentTRACK RECORD ►Customer engagement►Strategic partnership development and management►University in-licensing and collaborations►Product portfolio development►Go-to-market strategies►In-house and outsourced research and development►CRO/CMO evaluation and managementINVENTOR ►Inventor of over 30 patent families and developed the "Microjet Patch-pump" that won the Edison award in the Medical Device game-changer categoryVALUES►Honesty►Candor►Empathy ►Team Work►Changing the World with new Biotech Products - Saving Lives
Stealth Mode Startup Company
View-
Co-FounderStealth Mode Startup Company Aug 2023 - PresentUs
-
Co-FounderCage Bio Inc. Jun 2017 - PresentABOUT CAGE BIO INC.►Clinical stage biotech developing first-in-class therapeutics for leading dermatological conditions ►Novel Ionic Liquid platform enabling transdermal delivery of challenging small molecules, biologics, aptamers ►Developing products for rosacea, atopic dermatitis, alopecia indicationsPARTNERSHIP►Partnership with Nitto-Denko
-
Co-Founder, President And CeoI2O Therapeutics Mar 2019 - Aug 2023Cambridge, Massachusetts, UsABOUT i2o THERAPEUTICS INC.► Harvard spinout, developing first-in-class ionic-liquid based oral biologic products for major indications such as obesity (oral GLP1 and related incretins), diabetes, IBD►i2o is focused on creating the next generation of oral peptide and protein-based therapies►Funded by Morningside Ventures, Sanofi Ventures, JDRF, Touchdown, Viva, 7G, HM Capital and Colorcon Ventures ►Ongoing collaborations with Sanofi on oral nanobodies, Janseen on oral macromolecules, and with Colorcon on small molecules►Using an innovative ionic liquid technology, this platform leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across GI cell wall.CO-FOUNDER►Founded i2o Therapeutics in March 2019CEO►Joined as the CEO of i2o Therapeutics in March 2021ACHIEVEMENTS► Established 2 pharma partnerships in 9 months of company creation►Raised Capital from Marquee Investors►Recruited stellar team, board, SAB►In-licensed best-in-class GLP1 and incretin proprietary peptide pharma assets ►Business Plan Development►Drug Pipeline Buildout ($20B+ market targeting obesity via oral GLP1 and combination incretin peptides)►Established broad IP estate -
Founder, President And CeoOnconano Medicine Inc. Jan 2014 - Jan 2021FOUNDER►Founded and led company from lab bench university technology through Phase 2 clinical trials (with FDA fast track designation)RAISED CAPITAL ►Raised over $80MM+ in financingCOLLABORATIONS►Established two big pharma research collaborationsTHOUGHT-LEADER RECRUITMENT►Built marquee leadership and thought leader team ►Recruited Professor Charles Balch (ex-CEO ASCO, President MD Anderson) & Professor John Niederhuber (ex-head NCI, Chair of Surgery at Stanford and Johns Hopkins) to the SAB PRODUCT PIPELINE►Developed product pipeline of therapeutic and imaging products►Products deliver solutions across continuum of cancer care from early PET detection, intra-operative tumor imaging for surgery, therapeutic drugs (cytokines, STING agonists)►Technology platform exploits pH dysregulation in cancers- well established cancer hallmark► Ability to delivery small molecule, imaging, protein and peptide payloads to tumors and lymph nodesCLINICAL TRIALS►Lead product in Phase 2 trials with excellent safety and efficacy profile (100% patient response in 30 patients across 4 different tumors- breast, colorectal, esophegeal, head-and-neck; no SAEs)►Clinical Trials were conducted with Thought Leader PIs at leading cancer centers: Chairs of Surgery and Chair of Breast Cancer Surgery @ MD Anderson; Chair of Breast Surgery @ U Penn; Chair of Surgery @ UTSW;
-
Sr. Vice President, Research And DevelopmentS.E.A Medical Inc. Jul 2012 - Jan 2015ABOUT S.E.A. MEDICAL►Studies have shown IV administration error rate of up to 40% and causes over 7000 deaths in the US►S.E.A. Medical develops products to detect the drug composition, concentration and dose for use in several points in the drug chain from pharmacy to patient bedside IV-line to address this serious patient safety unmet medical needARTIFICIAL INTELLIGENCE (AI)►Built AI and Mission Learning Tools to enable drug identification R&D TEAM ►Led R&D team to develop products based on machine learning and novel sensors to prevent hospital drug medication errorsCOLLABORATION ►Managed a collaboration with Becton Dickinson
-
FounderStempar Sciences Inc. Jan 2010 - Aug 2012FOUNDER ►Founded the company to develop novel oncology small molecule drugs targeting key cancer stem cell and metabolism pathwaysABOUT STEMPAR SCIENCES INC.►The company was based on the collected scientific works of Prof. Sendurai Mani at MD Anderson cancer center (and MIT-Whitehead Institute), Prof. David Boothman and Prof. Jinming Gao at UT SouthWestern Medical Center, and Prof. Paul Hergenrother at the University of Illinois at Urbana
-
Member Of The Executive Management Team And BoardCorium Sep 2007 - Sep 2009Boston, Ma, UsABOUT CORIUM►Corium is an established trans-dermal drug delivery company with two FDA approved and three commercial products►Acquired by Gurnet Point ($500MM)SCOPE►Member of executive management team and board►Overall company strategy, planning, execution►Part of executive team that raised over $60MM in equity financingMICROJET►Co-head of Microjet drug delivery platform►Led the engineering and product development -
CofounderStratagent Life Sciences Jun 2002 - Sep 2007UsABOUT STRATAGENT LIFE SCIENCES►StrataGent Life Sciences developed a wearable "patch-pump" for delivering injectables such as insulin painlessly via the skinAWARDS►The product won the Edison award in the category of Medical Device Game ChangerTECHNICAL CO-FOUNDER►Led engineering and product development activities►Identified the market need and conceived of the product concept with other co-founders►In-licensed technology from Stanford University ►Miniaturized university prototype from desktop unit powered from mains, to wearable portable battery powered unitRAISED CAPITAL ►Raised over $20MM equity financingMERGER►Merged the company with Corium, an established transdermal company
Ravi Srinivasan Skills
Ravi Srinivasan Education Details
-
Massachusetts Institute Of TechnologyChemical Engineering -
Indian Institute Of Technology, BombayChemical Engineering
-
Massachusetts Institute Of TechnologyEngineering
Frequently Asked Questions about Ravi Srinivasan
What company does Ravi Srinivasan work for?
Ravi Srinivasan works for Stealth Mode Startup Company
What is Ravi Srinivasan's role at the current company?
Ravi Srinivasan's current role is Biotech Entrepreneur & CEO │Company Builder │Drug Developer │Capital Raise│Clinical Trials │Regulatory Strategy │Pharma Partnerships │ Obesity│ Oncology│ Immunology.
What is Ravi Srinivasan's email address?
Ravi Srinivasan's email address is ra****@****cal.com
What is Ravi Srinivasan's direct phone number?
Ravi Srinivasan's direct phone number is (303) 800*****
What schools did Ravi Srinivasan attend?
Ravi Srinivasan attended Massachusetts Institute Of Technology, Indian Institute Of Technology, Bombay, Massachusetts Institute Of Technology.
What are some of Ravi Srinivasan's interests?
Ravi Srinivasan has interest in Poverty Alleviation, Science And Technology, Environment, Health.
What skills is Ravi Srinivasan known for?
Ravi Srinivasan has skills like R&d, Medical Devices, Entrepreneurship, Technology Transfer, Product Development, Commercialization, Start Ups, Drug Delivery, Fda, Engineering, Biotechnology, Design Of Experiments.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial